Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...
Companies that put human flourishing at the center — by valuing genuine care, mutual benefit and shared purpose — financially outperform those focused on short-term transactions, now and going forward ...
PORTLAND, Ore. — Before the most important possession of Texas men's basketball season, several media members and fans all wondered aloud. They found out soon enough. Heide is a starter, but he hadn't ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results